The number of lives lost due to viral hepatitis infections is increasing and already accounts for 3,500 deaths daily, according to this report by the World Health Organization (WHO). This is the first consolidated WHO report on viral hepatitis epidemiology, service coverage and product access, with improved data for action. …
Human Trials For Inhalable Dose To Begin In India Next Year New Delhi: A single deep breath could soon vaccinate a child against measles. Next year, India will start human trials of a measles vaccine that will not require a syringe. Instead, a single long breath will deliver the vaccine …
The Global Alliance for Vaccines and Immunisation (GAVI) has decided to fund $165 million to assist India's pentavalent vaccine project. India would soon see introduction of the pentavalent vaccine as part of its National Immunisation Programme. A single shot of this vaccine would guard against diphtheria, tetanus, pertussis, Hepatitis B …
US-based Baxter International Inc formally announced on Wednesday that it completed production of its first commercial batches of A(H1N1) vaccine in late July and is discussing plans for distribution with national health authorities. The company will sell the vaccine under the brand name Celvapan, and claims it produced it within …
Nanda Kasabe Pune: Serum Institute of India (SII) is working at a furious pace on producing a H1N1 vaccine. SII is among the three labs selected by the WHO in India to develop the vaccine. So far, there has been no vaccine made of this kind anywhere worldwide and around …
In April, the company had announced that it had got the World Health Organisation contract to develop and manufacture the vaccine. The company is in talks with both the Drugs Controller General of India (DCGI) and the Indian Council of Medical Research (ICMR) to bring down the administrative time lag. …
The work on manufacturing of vaccines for H1N1 (swine flu) has begun in India, and now the World Health Oraganisation (WHO) is looking at it for the production of vaccines for the rest of the world as well. Speaking to The Indian Express, WHO Representative to India Dr S J …
In an alarming development, the first-ever case of vaccine-derived polio virus Type 2 has been reported from Uttar Pradesh. The news comes at a time when the Government was planning to do away with administration of trivalent vaccine in the state because of the absence of Type 2 polio virus. …
Shortage of affects Universal Immunisation Programme----- Lives of250 lakh children could be in danger this year, and probably another 250 lakh next year. They cannot be vaccinated because DPT and BCG vaccines are in short supply. Compared to 2007-2008, DPT (diphtheria-pertussis-tetanus) vaccination fell by 29 per cent in Orissa and …
New Experiment Shows Modified Parasites Can Be Used To Build Resistance In People In a daring experiment in Europe, scientists used mosquitoes as flying needles to deliver a
MARILYNN MARCHIONE In a daring experiment in Europe, scientists used mosquitoes as flying needles to deliver a "vaccine" of live malaria parasites through their bites. The results were astounding: Everyone in the vaccine group acquired immunity to malaria; everyone in a nonvaccinated comparison group did not, and developed malaria when …
The last time the prime minister bent too far to keep the coalition going WHEN the United Progressive Alliance (upa) was looking for partners after the 2004 general election, anyone was welcome. But has better judgment prevailed this time around? The coalition could ask itself this as it clears the …
A panel of health experts laid out a plan on Wednesday for vaccinating certain people first in the likely event that not enough swine flu vaccine will be available to immunize every American in time for the expected surge of cases this fall and winter. The top priority group, 159 …
Sushmi Dey THE World Health Organisation (WHO) has proposed a parallel review of vaccines manufactured by Indian companies, to be carried out by the Canadian national regulatory authority, in addition to the marketing approvals given by the Indian drug regulator.
LONDON: In a drive to inoculate people against A(H1N1) Influenza before winter, many European governments say they will fast-track the testing of a new flu vaccine, arousing concern among some experts about safety issues and proper vaccine doses. The European Medicines Agency, the EU
